Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-018987
Filing Date
2012-03-19
Accepted
2012-03-19 16:34:43
Documents
2
Period of Report
2012-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3242
2 POA DOCUMENT poa.txt EX-24.4_416841 1839
  Complete submission text file 0001209191-12-018987.txt   6408
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address
Bernard Gordon R (Reporting) CIK: 0001470015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 12700923